Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

26190151124_fa4ae08b82_b

Johnson & Johnson to spend over $100m to settle 1,000 talc powder lawsuits

October 7, 2020 Research and Development

Johnson & Johnson have agreed to pay over $100 million to settle more than 1,000 lawsuits that blame the company’s …
News
glenmark

FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis

October 7, 2020 Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis

Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …
News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020 Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 7, 2020 Research and Development COVID, COVID-19, corornavirus

The coronavirus news this week focuses on treatments, with Enlivex Therapeutics releasing positive data for its therapy Allocetra as a …
News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

October 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
Appointment
headache

Aimovig reduces frequency of episodic migraines, five-year data reveals

October 6, 2020 Manufacturing and Production, Research and Development Aimovig

Amgen and Novartis have revealed new five-year Phase 2 data during the Migraine Trust Virtual Symposium for their calcitonin gene-related …
News
fda2outsideweb

Opdivo/Yervoy combo secures FDA approval for malignant pleural mesothelioma

October 6, 2020 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Yervoy, bristol myers squibb, opdivo

Bristol Myers Squibb’s therapy regimen of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) has secured FDA approval for the first-line …
News
shutterstock_138095450

Alivio Therapeutics receives $3.3m from US Department of Defense to support development of IBD drug candidate

October 5, 2020 Research and Development, Sales and Marketing Alivio, US, ibd, pharma

The US Department of Defense (DoD) has committed a Technology/Therapeutic Development Award to the value of $3.3 million to biotech …
News
shutterstock_212432119

ViiV’s two-drug regimen proves non-inferior in treatment-naive HIV-1

October 5, 2020 Research and Development, Sales and Marketing HIV-1, ViiV Healthcare, pharma

ViiV Healthcare has taken the opportunity at the HIV Glasgow 2020 Virtual Congress to unveil three-year Phase 3 data from …
News
shutter

Remdesivir has a “favourable” benefit/risk profile in COVID-19 but more data needed, DSRU review argues

October 5, 2020 Research and Development, Sales and Marketing COVID-19, Drug Safety Research Unit, pharma, remdesivir

Southampton’s Drug Safety Research Unit (DSRU) has released a systematic benefit/risk analysis of Gilead’s antiviral drug remdesivir in the treatment …
News
banner

Across Health to hold first iD.cast webcast ‘Digital Acceleration in Biopharma’ on 15 October

October 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, event

Across Health is hosting its first iD.cast webcast, titled Digital Acceleration in Biopharma on 15 October. This ninety-minute webinar online …
News
vaccination-1215279_960_720

IGT Biologika’s COVID-19 vaccine becomes third in Germany to be approved for human trials

October 2, 2020 Medical Communications, Research and Development COVID-19, IDT Biologika, Vaccine

German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …
News
novartis_outside_1

Novartis unveils strong Phase 3 efficacy for one-time therapy Zolgensma in paediatric spinal muscular atrophy

October 1, 2020 Research and Development Novartis, Zolgensma, spinal muscular atrophy

Novartis has lifted the curtain on new Phase 3 data from an ongoing trial of 33 participants on the efficacy …
News
shutterstock_38078521

Enlivex’s Allocetra improves COVID-19 recovery times, early data show

October 1, 2020 Research and Development Allocetra, Enlivex

Israeli immunotherapy firm Enlivex Therapeutics has released tentatively positive data for its therapy Allocetra as a treatment for patients with …
News
800px-healthcare_workers_wearing_ppe_03

Coronavirus transmission in India driven by superspreaders

October 1, 2020 Research and Development

India’s largest contract tracing study has found that the virus has been transmitted through ‘super spreaders.’ The study was conducted …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026